Osorio Benedict
Insider CIK 1732730 · PRVB Chief Quality Officer · PGNX Senior Vice President, Quality
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRVB Provention Bio, Inc. | D To issuer deriv | 2023-04-27 | 2023-04-27 | 70,000 | — | $0 | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | D To issuer deriv | 2023-04-27 | 2023-04-27 | 80,000 | — | $0 | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | D To issuer deriv | 2023-04-27 | 2023-04-27 | 187,000 | — | $0 | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | D To issuer deriv | 2023-04-27 | 2023-04-27 | 100,000 | — | $0 | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2023-01-10 | 2023-01-11 | 187,000 | — | $0 | 187,000 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2022-12-08 | 2022-12-09 | 18,000 | — | $0 | 79,000 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2022-05-17 | 2022-05-18 | 9,000 | — | $0 | 61,000 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2022-01-18 | 2022-01-20 | 80,000 | — | $0 | 80,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 90,750 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 100,000 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 82,214 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer | 2020-06-19 | 2020-06-23 | 21,202 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2020-03-02 | 2020-03-04 | 82,214 | — | $0 | 82,214 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2019-03-01 | 2019-03-05 | 90,750 | — | $0 | 90,750 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2018-03-01 | 2018-03-02 | 100,000 | — | $0 | 100,000 | SEC↗ |